$MFA

MFA Financial (MFA) Q2 2026 Earnings Call Transcript

MFA Financial (MFA) reported Q2 2026 results on an earnings call. Investment portfolio rose to $13.0B from $12.5B as Agency MBS grew. GAAP net income was $46.8M ($0.35/share). Distributable earnings were $12.2M ($0.12/share) after $24.5M realized credit losses. 60+ delinquency fell to 7.0% after ~$200M delinquent loan resolutions; G&A run rate guidance was $26M-$27M/quarter.

Original reporting
Published Aug 12, 2026, 7:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MFA Financial (MFA) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$MFANeutralMed
01

Why it matters

Traders can update models for realized credit losses, EBV sensitivity to rates/spreads, and earnings power from delinquent-loan resolutions and expense run-rate reductions.

02

Market read

Key new trading inputs are the Q3 realized credit-loss expectation, the quantified delinquency improvement, and the stated 2% EBV decline since quarter-end.

03

What to watch

EBV is down about 2% post-quarter due to rates/spreads, and recourse leverage and resecuritization details could change risk metrics even if GAAP earnings look stable.

Relevance 7/10Novelty 6/10Timing: ahead of Q3 earnings positioning, after-hours call dated Aug. 5

Background

Conference call transcript for MFA Financial’s Q2 2026 results, covering portfolio composition, credit performance, expenses, and forward-looking expectations for Q3 and into 2027.

Company-level read

Ticker impact

$MFANeutralMedium confidence
Context

MFA reported Q2 results and guidance, including expected elevated realized credit losses in Q3 and a 2% post-quarter EBV decline.

Expected impact

Near-term bias likely mixed: support from delinquency resolution and expense run-rate reduction, offset by guidance for elevated Q3 realized credit losses and EBV decline.

Evidence & confidence

The article provides multiple quantified operating metrics (delinquency rate, realized credit losses, EBV change) plus an explicit Q3 credit-loss expectation, which should drive positioning around book/earnings sensitivity to rates and credit.

Market effects

Agency MBS share rising to nearly one-third may reinforce REIT/agency MBS read-throughs, while non-QM and legacy multifamily credit losses keep sector credit-risk premium in focus.

Primarily US housing credit and mortgage-backed securities exposure, with no explicit regional carve-outs.

Limited direct global linkage; rate and spread dynamics are US-centric but can influence global MBS/credit sentiment.

Counterpoint

The call suggests legacy credit noise is receding and delinquency improved; if realized credit losses moderate faster than guided, the market may re-rate MFA’s earnings power.

Key entities

  • MFA Financial, Inc.

    Subject of the earnings call, reporting Q2 metrics and expectations for Q3 realized credit losses, EBV movement, and portfolio deployment.

  • Craig Knutson

    CEO who commented on improving earnings power as legacy credit noise recedes.

  • Michael Roper

    CFO who guided realized credit losses to remain elevated in Q3 before moderating.

  • Bryan Wulfsohn

    President and CIO who discussed Agency MBS share and Lima One origination growth.

Related articles

$MFAMed

BTIG Upgrades MFA Financial (MFA), Expects Dividend Coverage to Improve

BTIG upgraded MFA Financial (NYSE:MFA) to Buy from Neutral on June 17, setting a $10.50 price target. BTIG expects improved dividend coverage as realized losses from MFA’s legacy portfolio ease in the second half of the year, supporting distributable earnings and narrowing the stock’s valuation discount. RBC on June 3 cut its target to $10 and flagged near-term credit-loss pressure.

$BHSTMed

BioHarvest Sciences Q2 Earnings Call Highlights

BioHarvest Sciences (NASDAQ:BHST) reported Q2 gross profit of $5.1M and a net loss of $3.7M ($0.17/share). Cash was $16.2M at June 30. 2026 revenue guidance was cut to $37M-$40M and EBITDA loss to $3M-$5M. Management tightened CDMO revenue to $4M-$5M and reduced VINIA outlook to $33M-$35M.

$SVCMedAI 8/10

Service Properties Trust (SVC) Q2 2026 Earnings Call Transcript

Service Properties Trust (SVC) reported Q2 2026 normalized FFO per share of $0.43, matching consensus. Retained hotel RevPAR rose 6.6% to $135 and retained hotel EBITDA increased 4.2% to $57 million. The company redeemed $550 million of unsecured debt using proceeds from a $542 million net equity offering and issued 2026 FFO guidance of $124 million to $144 million ($1.20 to $1.35/share).

$LZMedAI 8/10

LegalZoom (LZ) Q2 2026 Earnings Call Transcript

LegalZoom (LZ) reported Q2 2026 revenue of $205.3 million, up 7% year over year, driven by subscription revenue of $133.4 million (+11%). Transaction revenue fell 1% to $71.9 million. Adjusted EBITDA rose 18% to $45.9 million and free cash flow was $33.7 million. Full-year revenue guidance is $795-$805 million and adjusted EBITDA $190-$195 million.

$SNEXMedAI 8/10

StoneX (SNEX) Q3 2026 Earnings Call Transcript

StoneX Group Inc. (SNEX) reported Q3 FY2026 net operating revenues of $719.7 million, up 47% year over year, and net income of $127.9 million, up 102%. Diluted EPS was $1.00, up 85% after a 3-for-2 stock split. Segment results cited growth from R.J. O’Brien and The Benchmark acquisitions, plus a Shinhan Bank partnership.